Back to Awarded Treatment Trials
Awarded Trial: 00-226
Grant ID
00-226
Illness
Schizophrenia
Primary Drug/Intervention
D-Cycloserine
Primary Dosage
60 mg
Secondary Drug Intervention
Glycine
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Kee
Sample Size
45
Duration of Study Period for Each Subject
16 weeks
Outcome Measurements
Facial emotion identification, voice emotion
Results
Nineteen subjects were enrolled into the three arms of the study: cycloserine (n=7), glycine (n=6) or placebo (n=6). There were no significant differences between groups.
Publication
N/A
Link
N/A
PI Name
Kimmy Kee
Degree
PhD
Center
Greater Los Angeles Healthcare Center
Institution
UCLA/VA
Address
11301 Wilshire Blvd (MIRECC 210A), Bldg 210
City or Town
Los Angeles
State or Province
CA
Zip or Postal Code
90073
Country
USA
Email Address
kee@ucla.edu